Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cytokine and Visual Outcome Variations in Eyes Receiving a Variable Dosing Ranibizumab Treatment: The COVERT Study

NCT03056092 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT03056092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03056092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cytokine and Visual Outcome Variations in Eyes Receiving a Variable Dosing Ranibizumab Treatment: The COVERT Study
Lead sponsor
Unity Health Toronto
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2017
Completion date
February 28, 2024
Enrollment
168 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration, diabetic macular edema, macular edema, retinal vein occlusion